Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Pip, A Novel IRF Family Member, Is A Lymphoid-specific, PU.1-dependent Transcriptional Activator.
C. Eisenbeis, H. Singh, U. Storb
Published 1995 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
The immunoglobulin light-chain gene enhancers E kappa 3', E lambda 2-4, and E lambda 3-1 contain a conserved cell type-specific composite element essential for their activities. This element binds a B cell-specific heterodimeric protein complex that consists of the Ets family member PU.1 and a second factor (NF-EM5), whose participation in the formation of the complex is dependent on the presence of DNA-bound PU.1. In this report we describe the cloning and characterization of Pip (PU.1 interaction partner), a lymphoid-specific protein that is most likely NF-EM5. As expected, the Pip protein binds the composite element only in the presence of PU.1; furthermore, the formation of this ternary complex is critically dependent on phosphorylation of PU.1 at serine-148. The Pip gene is expressed specifically in lymphoid tissues in both B- and T-cell lines. When coexpressed in NIH-3T3 cells, Pip and PU.1 function as mutually dependent transcription activators of the composite element. The amino-terminal DNA-binding domain of Pip exhibits a high degree of homology to the DNA-binding domains of members of the interferon regulatory factor (IRF) family, which includes IRF-1, IRF-2, ICSBP, and ISGF3 gamma.
This paper references
Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor, IRF-1
T. Fujita (1989)
A large protein containing zinc finger domains binds to related sequence elements in the enhancers of the class I major histocompatibility complex and kappa immunoglobulin genes.
A. Baldwin (1990)
Physical linkage of mouse lambda genes by pulsed-field gel electrophoresis suggests that the rearrangement process favors proximate target sequences.
U. Storb (1989)
The Interferon System
W. Stewart (1981)
Molecular cloning of an enhancer binding protein:Isolation by screening of an expression library with a recognition site DNA
H. Singh (1988)
Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription.
N. Nelson (1993)
Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family.
C. Bovolenta (1994)
Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF
R. Hipskind (1991)
Different activation domains stimulate transcription from remote (‘enhancer’) and proximal (‘promoter’) positions.
K. Seipel (1992)
A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus
S. Pettersson (1990)
Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells.
M. Neuberger (1983)
The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB.
C. Hagemeier (1993)
Early events in signalling by interferons.
S. Pellegrini (1993)
A lymphocyte-specific enhancer in the mouse immunoglobulin κ gene
D. Picard (1984)
Transcriptional controlling elements in the immunoglobulin and T cell receptor loci.
K. Calame (1988)
The Oct-2 glutamine-rich and proline-rich activation domains can synergize with each other or duplicates of themselves to activate transcription.
M. Tanaka (1994)
Separate elements control DJ and VDJ rearrangement in a transgenic recombination substrate.
P. Ferrier (1990)
Deletion of the immunoglobulin kappa chain intron enhancer abolishes kappa chain gene rearrangement in cis but not lambda chain gene rearrangement in trans.
S. Takeda (1993)
Molecular Cloning: A Laboratory Manual
J. Sambrook (1983)
Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes
H. Harada (1989)
Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif
A. Courey (1988)
An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement.
Y. Chen (1994)
Expression of λ and K Genes Can Occur in all B Cells and is Initiated Around the Same Pre-B-Cell Developmental Stage
L. Doglio (1994)
Transcriptional regulation of interferon-stimulated genes.
B. Williams (1991)
The immunoglobulin kappa locus contains a second, stronger B‐cell‐specific enhancer which is located downstream of the constant region.
K. Meyer (1989)
Immunoglobulin gene transcription is activated by downstream sequence elements
C. Queen (1983)
Characterization of the human immunoglobulin kappa gene 3' enhancer: functional importance of three motifs that demonstrate B-cell-specific in vivo footprints.
J. G. Judde (1992)
PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.
J. Pongubala (1992)
Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator.
D. Kessler (1990)
A novel enhancer in the immunoglobulin lambda locus is duplicated and functionally independent of NF kappa B.
J. Hagman (1990)
A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene
S. Gillies (1983)
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.
M. Kozak (1987)
An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes.
P. Driggers (1990)
A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes
J. Banerji (1983)
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.
J. Darnell (1994)
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation.
J. Pongubala (1993)
Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis.
S. Rogers (1986)
The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain
N. Mermod (1989)
PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer.
C. Eisenbeis (1993)
Factors affecting the rearrangement efficiency of an Ig test gene.
P. Engler (1991)
Immunoglobulin gene transcription.
L. Staudt (1991)
17 – Factors Regulating Immunoglobulin-Gene Transcription
R. Sen (1989)
Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factors.
C. Rudin (1992)
Conserved motifs in Fos and Jun define a new class of activation domain.
J. A. Sutherland (1992)
Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes.
A. Weisz (1992)
Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element
S. Dalton (1992)
The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes.
C. Klug (1994)
A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes
H. Singh (1986)
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages.
E. Scott (1994)
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
M. Klemsz (1990)
This paper is referenced by
Shared and Distinct Functions of the Transcription Factors IRF4 and IRF8 in Myeloid Cell Development
Michio Yamamoto (2011)
Interferon Regulatory Factor 4 Is Involved in Epstein-Barr Virus-Mediated Transformation of Human B Lymphocytes
D. Xu (2008)
Mutation analysis of the Pip interaction domain reveals critical residues for protein-protein interactions.
M. A. Ortiz (1999)
IFN-α and IL-12 activate IFN regulatory factor 1 (IRF-1), IRF-4, and IRF-8 gene expression in human NK and T cells
A. Lehtonen (2003)
Regulation of IFN Regulatory Factor 4 Expression in Human T Cell Leukemia Virus-I-Transformed T Cells1
S. Sharma (2002)
Assembly and analysis of the mouse immunoglobulin kappa gene sequence
K. M. Brekke (2004)
The proto-oncogene c-myc in terminal B lymphocyte differentiation its role in plasma cell and memory B cell generation
Maitane Ortiz Virumbrales (2011)
Multiple PU.1 sites cooperate in the regulation of p40(phox) transcription during granulocytic differentiation of myeloid cells.
S. Li (2002)
Regulation of interleukin-12 production in antigen-presenting cells.
X. Ma (2001)
Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
S. Iida (1997)
Molecular Actions of Prolactin in the Immune System
L. Yu-Lee (1997)
Disabled‐2 is transcriptionally regulated by ICSBP and augments macrophage spreading and adhesion
F. Rosenbauer (2002)
IFN Regulatory Factor 4 and 8 Promote Ig Light Chain κ Locus Activation in Pre-B Cell Development1
S. Ma (2006)
Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage.
M. K. Anderson (1999)
Role of PU.1 in Hematopoiesis
R. C. Fisher (1998)
Regulation of Neutrophil Proteinases
A. Sturrock (1999)
Transcriptional regulation in neutrophils: teaching old cells new tricks.
P. P. McDonald (2004)
Plasma cells: finding new light at the end of B cell development
K. Calame (2001)
Interferon consensus sequence binding protein and interferon regulatory factor-4/Pip form a complex that represses the expression of the interferon-stimulated gene-15 in macrophages.
F. Rosenbauer (1999)
Spezies-spezifische und Zelltyp-spezifische Regulation von Toll-like Rezeptoren
Monika Lichtinger (2007)
Thyroid-specific gene expression
A. Sinclair (1994)
Epstein-Barr Virus EBNA-3C Is Targeted to and Regulates Expression from the Bidirectional LMP-1/2B Promoter
Carmilia Jiménez-Ramírez (2006)
Functions of the pointed domain within the ETS gene family
Jeffrey J Seidel (2001)
Interferon Regulatory Factor 4 (IRF4) Interacts with NFATc2 to Modulate Interleukin 4 Gene Expression
J. Rengarajan (2002)
Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma.
L. Colomo (2003)
Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b
M. Suzuki (2006)
Mef2 Proteins, Required for Muscle Differentiation, Bind an Essential Site in the Ig λ Enhancer
E. Satyaraj (1998)
IRF4 Does the Balancing Act: A Dissertation
R. Nayar (2015)
Transcriptional control of pre-B cell development and leukemia prevention.
S. H. Pang (2014)
IRF4 is a novel mediator for neuronal survival in ischaemic stroke
S. Guo (2014)
The molecular choreography of IRF4 and IRF8 with immune system partners.
H. Singh (2013)
Interactomics identifies novel regulators of the IRF-1 tumour suppressor protein
Vikram Narayan (2011)See more